Thiazolyldihydrocyclopentapyrazoles for use as PI3-kinase inhibitors

Details for Australian Patent Application No. 2007236045 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Grauert, Matthias; Hoenke, Christoph; Brandl, Trixi; Hoffmann, Matthias; Scheuerer, Stefan; Joergensen, Anne T.; Maier, Udo; Breitfelder, Steffen; Pragst, Ingo; Erb, Klaus; Pieper, Michael; Pautsch, Alexander

Agent Davies Collison Cave

Pub. Number AU-A-2007236045

PCT Pub. Number WO2007/115931

Priority 06112298.2 06.04.06 EP

Filing date 27 March 2007

Wipo publication date 18 October 2007

International Classifications

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 35/00 (2006.01) Antineoplastic agents

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

27 November 2008 PCT application entered the National Phase

  PCT publication WO2007/115931 Priority application(s): WO2007/115931

25 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007236046-Thiazolyl-dihydroquinazolines

2007236044-Thiazolyldihydroindazoles